Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-13

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for oxybutynin chloride filed by Teva Pharmaceuticals USA, Inc., encompassing a labeling change through a supplemental a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)